Peptit Liên Quan Đến Gen Calcitonin Ức Chế Các Yếu Tố Osteolytic Do Osteoblast Kích Thích Trong Hệ Thống Nuôi Cấy Kết Hợp Với Ung Thư Vú

Mercer, R. R., Miyasaka, C., & Mastro, A. M. (2004). Metastatic breast cancer cells suppress osteoblast adhesion and differentiation. Clinical & Experimental Metastasis, 21(5), 427–435. Virk, M. S., & Lieberman, J. R. (2007). Tumor metastasis to bone. Arthritis Research & Therapy, 9(S1), S5. Papantoniou, V., Sotiropoulou, E., Valsamaki, P., Tsaroucha, A., Sotiropoulou, M., Ptohis, N., et al. (2011). Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade. Breast Cancer, 18(4), 286–291. Rosenfeld, M. G., Mermod, J. J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., et al. (1983). Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature, 304(5922), 129–135. Yallampalli, C., Dong, Y. L., & Wimalawansa, S. J. (1996). Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by N(G)-nitro-l-arginine methyl ester. Human Reproduction, 11(4), 895–899. Petersen, K. A., Birk, S., Doods, H., Edvinsson, L., & Olesen, J. (2004). Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. British Journal of Pharmacology, 143(6), 697–704. Lu, J. T., Son, Y. J., Lee, J., Jetton, T. L., Shiota, M., Moscoso, L., et al. (1999). Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Molecular and Cellular Neuroscience, 14(2), 99–120. Ballica, R., Valentijn, K., Khachatryan, A., Guerder, S., Kapadia, S., Gundberg, C., et al. (1999). Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice. Journal of Bone and Mineral Research, 14(7), 1067–1074. Anders, C. K., Zagar, T. M., & Carey, L. A. (2013). The management of early-stage and metastatic triple-negative breast cancer: A review. Hematology/Oncology Clinics of North America, 27(4), 737–749. Mundy, G. R. (1997). Mechanisms of bone metastasis. Cancer, 80(8S), 1546–1556. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., et al. (1997). Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 89(5), 765–771. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89(5), 755–764. Gao, Y. H., Shinki, T., Yuasa, T., Kataoka-Enomoto, H., Komori, T., Suda, T., et al. (1998). Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: Regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochemical and Biophysical Research Communications, 252(3), 697–702. Liu, W., Toyosawa, S., Furuichi, T., Kanatani, N., Yoshida, C., Liu, Y., et al. (2001). Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. Journal of Cell Biology, 155(1), 157–166. Geoffroy, V., Kneissel, M., Fournier, B., Boyde, A., & Matthias, P. (2002). High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Molecular and Cellular Biology, 22(17), 6222–6233. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Lüthy, R., et al. (1997). Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell, 89(2), 309–319. Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., et al. (1998). Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Development, 12(9), 1260–1268. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93(2), 165–176. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America, 95(7), 3597–3602. Katagiri, T., & Takahashi, N. (2002). Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Diseases, 8(3), 147–159. Bu, G., Lu, W., Liu, C. C., Selander, K., Yoneda, T., Hall, C., et al. (2008). Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases. International Journal of Cancer, 123(5), 1034–1042. Zhu, J., Jia, X., Xiao, G., Kang, Y., Partridge, N. C., & Qin, L. (2007). EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: Implications for osteolytic bone metastases. Journal of Biological Chemistry, 282(37), 26656–26664. Villa, I., Mrak, E., Rubinacci, A., Ravasi, F., & Guidobono, F. (2006). CGRP inhibits steoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. American Journal of Physiology. Cell Physiology, 291(3), C529–C537. Ishizuka, K., Hirukawa, K., Nakamura, H., & Togari, A. (2005). Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Neuroscience Letters, 379(1), 47–51. Recober, A., & Goadsby, P. J. (2010). Calcitonin gene-related peptide: A molecular link between obesity and migraine? Drug News & Perspectives, 23(2), 112–117.